CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer
J. Clin. Invest. Stephan Roux, et al.
doi:10.1172/JCI35890 [Go to this article.]

Problems with a PDF?